![](https://ml.globenewswire.com/media/067475f8-416e-4d5f-a60f-26b19ea068dd/small/checkpointprimary-jpg.jpg)
Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for …